Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Neal

Showing results (371-380 of 484) with videos related to

Pageof 49
Sort By:
Nutrients|September 28, 2021
Barriers and Facilitators to Implementing Reduced-Sodium Salts as a Population-Level Intervention: A Qualitative StudyXuejun Yin, Maoyi Tian, Lingli Sun, et al.
Public Health Nutrition|February 14, 2023
Evaluation of a state-wide intervention on salt intake in primary schoolchildren living in Victoria, AustraliaCarley A Grimes, Kristy A Bolton, Kathy Trieu, et al.
Kidney International Reports|February 12, 2024
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A <i>Post Hoc</i> Analysis of CREDENCE TrialAkihiko Koshino, Brendon L Neuen, Megumi Oshima, et al.
The Lancet. Diabetes & Endocrinology|October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trialMegumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Heart (British Cardiac Society)|September 16, 2025
Predicting cardiovascular events from routine mammograms using machine learningJennifer Yvonne Barraclough, Ziba Gandomkar, Robert A Fletcher, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
Kidney International|August 5, 2023
Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetesTaha Sen, Wenjun Ju, Viji Nair, et al.
Hypertension (Dallas, Tex. : 1979)|March 11, 2024
Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac OutcomesJie Yu, Clare Arnott, Qiang Li, et al.
Journal of Nutritional Science|May 1, 2026
Sodium content of packaged foods and beverages in Nigeria: a cross-sectional comparative study with WHO global sodium benchmarks, Kenya, and South AfricaAdedayo E Ojo, Alexandra Jones, Kylie Howes, et al.
Diabetologia|August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS ProgramTamara K Young, Jing-Wei Li, Amy Kang, et al.
Pageof 49

Showing results (371-380 of 484) with videos related to

Sort By:
Pageof 49
Nutrients|September 28, 2021
Barriers and Facilitators to Implementing Reduced-Sodium Salts as a Population-Level Intervention: A Qualitative StudyXuejun Yin, Maoyi Tian, Lingli Sun, et al.
Public Health Nutrition|February 14, 2023
Evaluation of a state-wide intervention on salt intake in primary schoolchildren living in Victoria, AustraliaCarley A Grimes, Kristy A Bolton, Kathy Trieu, et al.
Kidney International Reports|February 12, 2024
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A <i>Post Hoc</i> Analysis of CREDENCE TrialAkihiko Koshino, Brendon L Neuen, Megumi Oshima, et al.
The Lancet. Diabetes & Endocrinology|October 16, 2020
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trialMegumi Oshima, Brendon L Neuen, Meg J Jardine, et al.
Heart (British Cardiac Society)|September 16, 2025
Predicting cardiovascular events from routine mammograms using machine learningJennifer Yvonne Barraclough, Ziba Gandomkar, Robert A Fletcher, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
Kidney International|August 5, 2023
Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetesTaha Sen, Wenjun Ju, Viji Nair, et al.
Hypertension (Dallas, Tex. : 1979)|March 11, 2024
Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac OutcomesJie Yu, Clare Arnott, Qiang Li, et al.
Journal of Nutritional Science|May 1, 2026
Sodium content of packaged foods and beverages in Nigeria: a cross-sectional comparative study with WHO global sodium benchmarks, Kenya, and South AfricaAdedayo E Ojo, Alexandra Jones, Kylie Howes, et al.
Diabetologia|August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS ProgramTamara K Young, Jing-Wei Li, Amy Kang, et al.
Pageof 49